Synthomer (LON:SYNT – Get Free Report) had its target price lowered by research analysts at Canaccord Genuity Group from GBX 300 ($4.01) to GBX 275 ($3.68) in a research note issued to investors on Friday, MarketBeat.com reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price points to a potential upside of 38.75% from the stock’s current price.
A number of other research analysts have also issued reports on SYNT. Jefferies Financial Group boosted their price objective on Synthomer from GBX 220 ($2.94) to GBX 250 ($3.34) and gave the company a “hold” rating in a research report on Friday, July 12th. Berenberg Bank cut their target price on Synthomer from GBX 375 ($5.02) to GBX 340 ($4.55) and set a “buy” rating on the stock in a research note on Tuesday, August 13th.
Get Our Latest Report on Synthomer
Synthomer Stock Performance
Synthomer Company Profile
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Featured Articles
- Five stocks we like better than Synthomer
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 9/30 – 10/4
- What is the Hang Seng index?
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.